Epigral Limited
Stock Forecast, Prediction & Price Target
Epigral Limited Financial Estimates
Epigral Limited Revenue Estimates
Epigral Limited EBITDA Estimates
Epigral Limited Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 3/31/2021 | 3/31/2022 | 3/31/2024 | 3/31/2026 | |||
Revenue
% change YoY
| ₹8.25B N/A | ₹15.49B 87.63% | ₹18.97B 22.41% | Avg: ₹23.19B Low: ₹23.19B High: ₹23.19B avg. 22.23% | |||
Net Income
% change YoY
| ₹1.00B N/A | ₹2.52B 150.68% | ₹1.95B -22.51% | Avg: ₹2.63B Low: ₹2.63B High: ₹2.63B avg. 34.28% | |||
EBITDA
% change YoY
| ₹2.65B N/A | ₹5.00B 88.40% | ₹4.76B -4.71% | Avg: ₹7.00B Low: ₹7.00B High: ₹7.00B avg. 46.90% | |||
EPS
% change YoY
| $24.27 N/A | $60.84 150.67% | $47.14 -22.51% | Avg: $63.3 Low: $63.3 High: $63.3 avg. 34.28% | |||
Operating Expenses
% change YoY
| ₹2.25B N/A | ₹3.24B 43.85% | ₹1.02B -68.38% | Avg: ₹783.29M Low: ₹783.29M High: ₹783.29M avg. -23.67% |
FAQ
What is Epigral Limited stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 34.28% in 2026-2026.
We have gathered data from N/A analysts. Their low estimate is 2.63B, average is 2.63B and high is 2.63B.
What is Epigral Limited stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 22.23% in 2026-2026.
We have gathered data from N/A analysts. Their low revenue estimate is ₹23.19B, average is ₹23.19B and high is ₹23.19B.
What is Epigral Limited stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 34.28% in 2026-2026.
We have gathered data from N/A analysts. Their low earnings per share estimate is $63.3, average is $63.3 and high is ₹63.3.